Cargando…
ADGRG1 Is a Predictor of Chemoresistance and Poor Survival in Cervical Squamous Carcinoma
BACKGROUND: Cisplatin is the first-line chemotherapy for cervical cancer. Cisplatin resistance has always been one of the most significant barriers to acquiring better outcomes. However, the complex molecular mechanisms accounting for the phenomenon are not completely clear. METHODS: Construction of...
Autores principales: | Zhang, Shuo, Guo, Kui, Liang, Ying, Wang, Kun, Liu, Shuyan, Yang, Xingsheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8340018/ https://www.ncbi.nlm.nih.gov/pubmed/34367958 http://dx.doi.org/10.3389/fonc.2021.671895 |
Ejemplares similares
-
The Activation and Signaling Mechanisms of GPR56/ADGRG1 in Melanoma Cell
por: Huang, Kuan-Yeh, et al.
Publicado: (2018) -
ER-α36 Promotes the Malignant Progression of Cervical Cancer Mediated by Estrogen via HMGA2
por: Wang, Chunyan, et al.
Publicado: (2021) -
The Adhesion G-Protein-Coupled Receptor, GPR56/ADGRG1, Inhibits Cell–Extracellular Matrix Signaling to Prevent Metastatic Melanoma Growth
por: Millar, Michelle W., et al.
Publicado: (2018) -
MGL Ligand Expression Is Correlated to Lower Survival and Distant Metastasis in Cervical Squamous Cell and Adenosquamous Carcinoma
por: Sahasrabudhe, Neha M., et al.
Publicado: (2019) -
Overexpression of Mena is associated with tumor progression and poor prognosis in oral squamous cell carcinoma via EMT
por: Na, Sijia, et al.
Publicado: (2022)